Syros Pharmaceuticals, Inc.

NASDAQ:SYRS

2.61 (USD) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q4
Revenue 0000.3863.7622.8332.954-5.4673.8916.2765.4677.8025.6975.1624.8275.6993.8283.1882.3790.5080.5580.4620.4540.8930.4120.3750.370001.1010.317000000.31700
Cost of Revenue 0.3250.3310.3340.2790.6160.6530.7040.770.7240.7260.74700000000000000000000000000000
Gross Profit -0.325-0.331-0.3340.1073.1462.182.25-6.2373.1675.554.727.8025.6975.1624.8275.6993.8283.1882.3790.5080.5580.4620.4540.8930.4120.3750.370001.1010.317000000.31700
Gross Profit Ratio 0000.2770.8360.770.7621.1410.8140.8840.86311111111111111110001100000100
Reseach & Development Expenses 20.52721.62224.32121.22428.2829.60828.76127.91425.75933.125.17126.79527.26225.78620.02929.02617.67414.79614.56914.27715.93115.47512.56215.12812.85611.08211.11611.7810.44710.0419.6288.44311.5849.5258.2658.3786.8665.4283.7363.022
General & Administrative Expenses 5.6555.4636.2665.8887.7647.2257.4057.3298.0766.9456.9496.435.3465.525.7395.8925.1515.1335.1496.4015.0165.1954.8654.3723.8763.8414.0753.743.5933.4723.0862.9192.6332.542.3712.3111.5980.9840.8360.669
Selling & Marketing Expenses 0000000000000000000000000000000000000000
SG&A 5.6555.4636.2665.8887.7647.2257.4057.3298.0766.9456.9496.435.3465.525.7395.8925.1515.1335.1496.4015.0165.1954.8654.3723.8763.8414.0753.743.5933.4723.0862.9192.6332.542.3712.3111.5980.9840.8360.669
Other Expenses 0-21.95300.1352.354009.51-9.510000000-0.489-0.4550.1130.4410.5960.7530.5120.5750.5830.5010.3580.2180.2150.1450.0980.080.0480.0440.04800-0.0020.0040
Operating Expenses 26.18227.08530.58727.11238.39836.83336.16635.24333.83540.04532.1233.22532.60831.30625.76834.91822.82519.92919.71820.67820.94720.6717.42719.516.73214.92315.19115.5214.0413.51312.71411.36214.21712.06510.63610.6898.4646.4124.5723.693
Operating Income -26.182-27.416-30.921-27.005-34.636-34-33.212-35.997-39.454-33.769-26.653-25.423-26.911-26.144-20.941-29.219-18.997-16.741-17.339-20.17-20.389-20.208-16.973-18.607-16.32-14.548-14.821-15.52-14.04-13.513-11.613-11.045-14.217-12.065-10.636-10.689-8.464-6.095-4.572-3.691
Operating Income Ratio 000-69.961-9.207-12.001-11.2436.584-10.14-5.381-4.875-3.259-4.724-5.065-4.338-5.127-4.963-5.251-7.288-39.705-36.539-43.74-37.385-20.837-39.612-38.795-40.057000-10.548-34.84200000-19.22700
Total Other Income Expenses Net 19.7864.08927.213-37.379-8.191-3.1059.42331.2239.201-0.7121.5072.5651.8364.6117.670.455-0.489-0.4550.1130.4410.5960.7530.5120.5750.5830.5010.3580.2180.2150.1450.0980.080.0480.0440.04800-0.0020.0040.002
Income Before Tax -6.396-23.327-3.708-64.384-40.143-36.258-23.789-4.774-30.253-34.481-25.146-23.813-26.027-22.49-14.228-30.13-19.486-17.196-17.226-19.729-19.793-19.455-16.461-18.032-15.737-14.047-14.463-15.302-13.825-13.368-11.515-10.965-14.169-12.021-10.588-10.689-8.464-6.097-4.568-3.689
Income Before Tax Ratio 000-166.798-10.671-12.798-8.0530.873-7.775-5.494-4.6-3.052-4.569-4.357-2.948-5.287-5.09-5.394-7.241-38.837-35.471-42.11-36.258-20.193-38.197-37.459-39.089000-10.459-34.5900000-19.23300
Income Tax Expense -0.32500.29110.883-3.2961.278-8.865-32.349-9.2010.712-1.5070.9860.9840.9690.9671.41700000000000-0.39000000000001.137
Net Income -6.396-23.327-3.708-64.384-40.143-36.258-14.92427.575-21.052-35.193-23.639-23.813-26.027-22.49-14.228-30.13-19.486-17.196-17.226-19.729-19.793-19.455-16.461-18.032-15.737-14.047-14.463-15.302-13.825-13.368-11.515-10.965-14.169-12.021-10.588-10.689-8.464-6.097-4.568-4.826
Net Income Ratio 000-166.798-10.671-12.798-5.052-5.044-5.41-5.608-4.324-3.052-4.569-4.357-2.948-5.287-5.09-5.394-7.241-38.837-35.471-42.11-36.258-20.193-38.197-37.459-39.089000-10.459-34.5900000-19.23300
EPS -0.16-0.59-0.095-2.18-1.43-1.3-0.540.99-2.24-5.51-3.75-3.78-4.14-3.6-2.32-4.91-4.26-3.76-3.92-4.6-4.66-4.67-4.87-5.35-4.68-4.27-4.77-5.81-5.26-5.23-4.92-4.69-6.44-47.08-4.65-5.96-33.15-23.88-2.55-29.78
EPS Diluted -0.16-0.59-0.095-2.18-1.43-1.3-0.540.99-2.24-5.51-3.75-3.78-4.14-3.58-2.32-4.91-4.26-3.76-3.92-4.49-4.66-4.67-4.87-5.34-4.68-4.27-4.77-5.81-5.26-5.23-4.92-4.69-6.44-47.08-4.65-5.96-33.15-23.88-2.55-29.78
EBITDA -26.182-27.085-30.587-26.726-34.636-31.225-30.799-33.634-38.338-32.931-25.871-24.619-26.114-25.383-20.2-28.4-18.23-15.984-16.596-19.272-19.746-19.559-16.441-18.175-15.912-14.172-14.433-15.52-13.649-13.132-11.248-10.707-13.902-11.749-10.332-10.46-8.275-5.985-4.498-3.62
EBITDA Ratio 000-69.238-9.207-11.022-10.4266.152-9.853-5.247-4.732-3.155-4.584-4.917-4.185-4.983-4.762-5.014-6.976-37.937-35.387-42.335-36.214-20.353-38.621-37.792-39.008000-10.216-33.77600000-18.8800